Translate

Friday, February 8, 2019

TB survivors file challenge to prevent J&J from extending patent life on Bedaquiline

Two tuberculosis survivors have filed a patent challenge on Johnson and Johnson’s TB drug Bedaquiline.Nandita Venkatesan from Mumbai and Phumeza Tisil
Source: BHT